Clinical Trials Directory

Trials / Completed

CompletedNCT00867997

Noncarious Cervical Lesion Treatment Outcomes

Noncarious Cervical Lesion Treatment Outcomes: Randomized Clinical Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
304 (actual)
Sponsor
Pearl Network · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The overall objective of this three-armed randomized clinical trial (RCT) is to determine the comparative efficacy of three treatments for hypersensitive noncarious cervical lesions (NCLs): chemoactive dentifrice use, dentin bonding agent (DBA) with sealing, and flowable resin-based composite restoration. The primary outcomes of this study are the reduction/elimination of hypersensitivity and the effect of treatment as measured by patient-reported outcomes. Secondary outcomes, as determined by laboratory evaluation of intraoral replicas of pre- and posttreatment NCL surfaces, are tubule occlusion, retention of resin coating, retention of restoration, and change in lesion size. Outcomes will be ascertained via the following specific aims: Specific Aim 1: To compare the reduction of hypersensitivity of study teeth by both measurement and by patient-reported outcomes among three treatment groups. Specific Aim 2: To recruit subjects with teeth with hypersensitive NCLs, measure baseline sensitivity and subject quality of life, administer one of three different treatments to each of three randomized groups of subjects, and determine immediate posttreatment hypersensitivity. Specific Aim 3: To compare the degree of tubule occlusion before and after the three treatments and to associate these findings with posttreatment hypersensitivity, patient-reported outcomes, and restoration retention. Treatment of NCLs remains controversial. Few studies have compared treatment methods or their financial implications. This RCT will determine the reduction of NCL hypersensitivity and patient-reported outcomes over a 6-month period for each of three different treatments. This will be the first practice-based research network RCT to combine objective clinical assessment of NCL treatment patient-reported outcomes with laboratory examination of dentin tubule occlusion and lesion size.

Conditions

Interventions

TypeNameDescription
OTHERChemoactive (remineralizing, neuroactive) dentifrice treatmentChemoactive (remineralizing, neuroactive) dentifrice treatment
OTHERClearfil S3 Bond; Clearfil Liner Bond 2 Protect Liner FSelf-etch DBA followed by a hydrophobic resin layer
OTHERClearfil S3 Bond; Premise Flowable resin-based compositeRestoration with a dentin bonding agent (DBA) and flowable resin-based composite

Timeline

Start date
2009-03-01
Primary completion
2011-07-01
Completion
2012-02-01
First posted
2009-03-24
Last updated
2012-02-29

Locations

17 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00867997. Inclusion in this directory is not an endorsement.